Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Kelly Byrnes-Blake"'
Autor:
Kelly Byrnes-Blake, Kate Slovik, Joseph Rucker, Ileine Sanchez, Kyle Doolan, Breanna Tyrell, Anna Lobley, Nicholas Molino, Kristin Shema, Kyle Guldner, Hayley Roth, Alyssa Cunningham, Eric Butz, Stanley Roberts, Riley Payne, Ed Calamai, Ross Chambers
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/eaa8b95d0cde48acbfa27244651580da
Autor:
Miko Yamada, Dennis M. Miller, Melinda Lowe, Casey Rowe, Dominic Wood, H. Peter Soyer, Kelly Byrnes-Blake, Julia Parrish-Novak, Laura Ishak, James M. Olson, Gordon Brandt, Paul Griffin, Lynda Spelman, Tarl W. Prow
Publikováno v:
Contemporary Clinical Trials Communications, Vol 23, Iss , Pp 100830- (2021)
BLZ-100 (tozuleristide) is an intraoperative fluorescent imaging agent that selectively detects malignant tissue and can be used in real time to guide tumor resection. The purpose of this study was to assess the safety, tolerability, and pharmacokine
Externí odkaz:
https://doaj.org/article/ad83bdf155494bdf86da445659b9b372
Autor:
Melinda Lowe, Kelly Byrnes-Blake, H. Peter Soyer, James M. Olson, Dennis M. Miller, Lynda Spelman, Paul M. Griffin, Laura Ishak, Casey Rowe, Dominic Wood, Tarl W. Prow, Gordon Brandt, Miko Yamada, Julia Parrish-Novak
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 23, Iss, Pp 100830-(2021)
Contemporary Clinical Trials Communications, Vol 23, Iss, Pp 100830-(2021)
BLZ-100 (tozuleristide) is an intraoperative fluorescent imaging agent that selectively detects malignant tissue and can be used in real time to guide tumor resection. The purpose of this study was to assess the safety, tolerability, and pharmacokine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16bed6ca26387b43b013ceb67317167e
https://hdl.handle.net/11541.2/29413
https://hdl.handle.net/11541.2/29413
Autor:
Mesfin M. Gewe, Fiona Pakiam, Natalie Nairn, Kelly Byrnes-Blake, Mi-Youn Brusniak, Dennis M. Miller, Christopher Mehlin, James M. Olson, Andrew D. Strand, Chunfeng Yin, Colin Correnti, Elizabeth Nguyen, Raymond O. Ruff, Julian A. Simon, Roland K. Strong, Emily J. Girard, Gene Hopping, Michelle L. Cook Sangar, Andrew J. Mhyre
Publikováno v:
Science Translational Medicine. 12
On-target, off-tissue toxicity limits the systemic use of drugs that would otherwise reduce symptoms or reverse the damage of arthritic diseases, leaving millions of patients in pain and with limited physical mobility. We identified cystine-dense pep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb8e9f5645def92387f60bddb4a13f27
https://doi.org/10.1126/scitranslmed.aay1041
https://doi.org/10.1126/scitranslmed.aay1041
Autor:
Adam N. Mamelak, Dennis M. Miller, Kelly Byrnes-Blake, Jeff Perry, Chirag G. Patil, David G. Walker, Stacey Hansen, Pramod Butte, Lynlee L. Lin, Kaitlin L. Nufer, Miko Yamada, Keith L. Black, David S. Kittle, Beth Morrison, Tarl W. Prow, Laura Ishak, Julia Parrish-Novak, Kim Pham
BACKGROUND: Fluorescence-guided surgery (FGS) can improve extent of resection in gliomas. Tozuleristide (BLZ-100), a near-infrared imaging agent composed of the peptide chlorotoxin and a near-infrared fluorophore indocyanine green, is a candidate mol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a5adae0f22f6edceb7a4d45ace9edce
https://hdl.handle.net/11541.2/140123
https://hdl.handle.net/11541.2/140123
Autor:
Susan H. Julien, Kelly Byrnes-Blake, Jeremy A Freeman, Katherine E. Lewis, Mark W. Rixon, Matthew S. Holdren, M.F. Maurer, Brent Meengs, Stacey R. Dillon, S. Underwood, Thomas R. Bukowski, Nels Hamacher, A.C. Wolf
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 31:142-150
Background Overexpression or administration of interleukin 31 (IL-31) has been shown to induce a profound itch response in mice and dogs. The chronic pruritus observed in mouse IL-31 transgenic mice results in the development of skin lesions and alop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a467f62858b148afbeda19d209f05236
https://doi.org/10.1111/jdv.13794
https://doi.org/10.1111/jdv.13794
Autor:
Narine Lalayeva, William S. Dernell, Rhonda Gilmore, Stacey Hansen, Janean Fidel, Gregory A. Bricker, Julia Parrish-Novak, K. S. Tarlo, Pamela Gayheart-Walsten, Valorie R. Wiss, Stefanie C.M. Burleson, James M. Olson, Dennis M. Miller, Errol Malta, Kelly Byrnes-Blake, William J. Crumb
Publikováno v:
International journal of toxicology. 36(2)
BLZ-100 is a single intravenous use, fluorescent imaging agent that labels tumor tissue to enable more complete and precise surgical resection. It is composed of a chlorotoxin peptide covalently bound to the near-infrared fluorophore indocyanine gree
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d31c1f16a927cff7f126b19085c8cd0
https://pubmed.ncbi.nlm.nih.gov/28403743
https://pubmed.ncbi.nlm.nih.gov/28403743
Autor:
K Lau, P Smolak, Daniel Burge, Richard J. Martin, Y Sherrer, R Levin, J Eisenman, James Posada, Alan Kivitz, Stanley Cohen, Kelly Byrnes-Blake
Publikováno v:
Lupus. 26(8)
Blood-borne RNA circulating in association with autoantibodies is a potent stimulator of interferon production and immune system activation. RSLV-132 is a novel fully human biologic Fc fusion protein that is comprised of human RNase fused to the Fc d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0bffa27b2e3f17048498b3773bc94ea
https://pubmed.ncbi.nlm.nih.gov/27852935
https://pubmed.ncbi.nlm.nih.gov/27852935
Autor:
Amy Lee, Laura Ishak, David Walker, Chirag G. Patil, Sarah Leary, Carolyn Gombotz, Dennis M. Miller, Kelly Byrnes-Blake
Publikováno v:
Journal of Clinical Oncology. 36:e14562-e14562
e14562Background: Tozuleristide (BLZ-100) is a fluorescent imaging agent intended to highlight tumor tissue in patients undergoing surgical tumor resection. The pharmacokinetics (PK) of BLZ-100 in ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbfeee30ce1510477edc35119dd60bf8
https://doi.org/10.1200/jco.2018.36.15_suppl.e14562
https://doi.org/10.1200/jco.2018.36.15_suppl.e14562
Autor:
Stuart C. Gordon, Mitchell L. Shiffman, Paul Marotta, Jeremy A Freeman, Diana F. Hausman, John M. Vierling, Andrew J. Muir, Atif Zaman, Naomi Hunder, Kelly Byrnes-Blake, Eric Lawitz, Juan Carlos Lopez-Talavera, Steven L. Flamm, D. Fontana, Boris Yoffe, T. Gray, Andrew N. de la Torre
Publikováno v:
Hepatology. 52:822-832
Interferon lambda 1 (IFN-lambda1) is a type III IFN that produces intracellular responses similar to those of IFN-alpha but in fewer cell types because of differences in the receptor distribution pattern, and this could potentially result in an impro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3a23fed11510296abf819fc65fbcd4
https://doi.org/10.1002/hep.23743
https://doi.org/10.1002/hep.23743